News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Fnu Vikash: Honored to Receive the 2024 AASLD Foundation Emerging Liver Scholar Award
Photo taken from Fnu Vikash/X
Jun 24, 2024, 14:49

Fnu Vikash: Honored to Receive the 2024 AASLD Foundation Emerging Liver Scholar Award

Fnu Vikash, PGY-1 at Albert Einstein College of Medicine, made the following post on X:

“Honored and Excited to Receive the 2024 AASLD Foundation Emerging Liver Scholar Award!

Thank you to my amazing mentors for their unwavering support and guidance

Looking forward to learning & sharing knowledge with fellow liver enthusiasts.”

Fnu Vikash

Source: Fnu Vikash/X

AASLD Foundation academic achievement Albert Einstein College of Medicine cancer Emerging Liver Scholar Award Fnu Vikash liver disease liver research medical awards medical education mentorship in medicine OncoDaily Oncology PGY-1
Blog
Jun 29, 2024, 14:39
David Kombe described the Home Away From Home project - CCI
Career
Jun 29, 2024, 14:34
Thordur Oskarsson received the exceptional project grant from Breast Cancer Alliance for breast cancer research - Moffitt Cancer Center
Insight
Jun 29, 2024, 14:29
New risk assessment by Deborah Siegal at ISTH2024
Blog
Jun 29, 2024, 14:26
QUANTRO Therapeutics Achieves Milestone with Boehringer Ingelheim in Developing First-in-Class Cancer Treatments
Societies
Jun 29, 2024, 14:24
KRAS - the most commonly mutated oncogene in cancer
Blog
Jun 29, 2024, 14:20
Kimberley Neve at Cancer Prevention Research Conference
Opinion
Jun 29, 2024, 14:18
Fear of Recurrence – source of cancer return? - a psycho-oncological perspective from Adrian Pogacian
Insight
Jun 29, 2024, 14:16
Anbu Paramasivam: Day 1 of Prevention Conference 2024
Societies
Jun 29, 2024, 14:13
Wellbeing Week at Iris Care Group
Insight
Jun 29, 2024, 14:09
Fumiko Ladd Chino: Did you know that the prior authorisation reform bill was reintroduced into Congress
Insight
Jun 29, 2024, 14:04
Piotr Wysocki: Combination of nivolumab and relatlimab in neoadjuvant setting in resectable NSCLC
Drugs
Jun 29, 2024, 13:50
Chemotherapy with adjuvant nivolumab versus placebo for GEJ cancer